Allogeneic natural killer cell therapy
2022 · Blood · 193 citations
https://doi.org/10.1182/blood.2022016200
M
Miriam T. Jacobs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
2.1K
Citations
20
h-index
26
i10-index
Miriam T. Jacobs is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 20, co-authored 92 publications.
ORCID: 0000-0002-8831-7592Papers by this author
worksUse of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non–Small-Cell Lung Cancer: A Multicenter Case Series
2018 · JCO Precision Oncology · 17 citations
https://doi.org/10.1200/po.17.00318
Memory-like differentiation enhances NK cell responses against colorectal cancer
2024 · OncoImmunology · 8 citations
https://doi.org/10.1080/2162402x.2024.2348254
Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
2021 · Blood · 6 citations
https://doi.org/10.1182/blood-2021-147488
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma
2025 · The Journal of Immunology · 4 citations
https://doi.org/10.1093/jimmun/vkae004
Supplementary Table S1 from Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27034147
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat